Diplopia and Quality of Life in Patients with Baerveldt 250 Compared to Ahmed FP7 Glaucoma Drainage Devices
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 17-003916
Sponsor Protocol Number: 17-003916
About this study
The purpose of our prospective study is to compare the prevalence of diplopia following 250 Baerveldt and FP7 Ahmed, and to characterize the specific types, causes, and effect of diplopia in these two groups.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Adult surgical glaucoma patients who will be receiving either 250 Baerveldt or FP7 Ahmed
- Patients with previous cataract and/or failed trabeculectomy surgery, selective laser trabeculoplasty, trabectome, iStent will be included
Exclusion Criteria:
- Patients with multiple GDD, patients with GDD in quadrants other than superior temporal location, and patients with previous scleral buckle will be excluded.
- Patients will not be recruited if they cannot read or understand English or if they have severe cognitive impairment prohibiting completion of surveys.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Cheryl Khanna, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available